References
- 1. World Health Organization Information Kit on Epilepsy - What you can do, WHO, Geneva 2015, pp. 1-42; http://www.who.int/mental_health/neurology/epilepsy/epilepsy_global_toolkit.pdf, last access date December 19, 2015.
- 2. D. Schmidt and W. Loscher, Drug resistance in epilepsy, Putative neurobiologic and clinical mechanisms, Epilepsia 46 (2005) 858-877; DOI: 10.1111/j.1528-1167.2005.54904.x.
- 3. D. Battino, G. Dukes and E. Perucca, Anticonvulsant, in Meyler’s Side Effects of Drugs - An Encylcopedia of Adverse Reactions and Interactions (Eds. M. N. G. Dukes and J. K. Aronson), 14th ed., Elsevier Science Publishers, New York 2000, pp. 164-197.
- 4. J. M. L. Lima, The new drugs and the strategies to manage epilepsy, Curr. Pharm. Des. 6 (2008) 873-878; DOI: 10.2174/1381612003400308.
- 5. A. Thiry, J. M. Dogne, C. T. Supuran and B. Masereel, Carbonic anhydrase inhibitors as anticonvulsant agents, Curr. Top. Med. Chem. 7 (2007) 855-864; DOI: 10.2174/156802607780636726.
- 6. M. J. Brodie, Do we need any more new antiepileptic drugs? Epilepsy Res. 45 (2001) 3-6; DOI: 10.1016/S0920-1211(01)00203-0.
- 7. C. L. P. Deckers, P. Genton, G. J. Sills and D. Schmidt, Current limitations of antiepileptic drug therapy, a conference review, Epilepsy Res. 53 (2003) 1-17; DOI: 10.1016/S0920-1211(02)00257-7.
- 8. B. Malawska, New anticonvulsant agents, Curr. Top. Med. Chem. 5 (2005) 69-85; DOI: 10.2174/1568026053386944.
- 9. D. Choi, J. P. Stables and H. Kohn, Synthesis and anticonvulsant activities of N-benzyl-2-acetamido- propionamide derivatives, J. Med. Chem. 39 (1996) 1907-1916; DOI: 10.1021/jm9508705.
- 10. A. H. Tarikogullari, F. S. Kilic, K. Erol and V. Pabuccuoglu, Synthesis and anticonvulsant activity of some alkanamide derivatives, Arzneimittelforsch. 60 (2010) 593-598; DOI: 10.1055/s-0031-1296331.
- 11. S. N. Pandeya, P. Yogeeswari and J. P. Stables, Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones, Eur. J. Med. Chem. 35 (2000) 879-886; DOI: 10.1016/S0223-5234(00)01169-7.
- 12. K. M. Basavaraja, V. P. Vaidya and C. Chandrashekhar, Synthesis of benzofuro[3,2-e]-1,4-diazepines of pharmacological interest, Eur. J. Chem. 5 (2008) 567-571; DOI: 10.1155/2008/920926.
- 13. K. M. Dawood, H. Abdel-Gawad, E. A. Rageb, M. Ellithey and H. A. Mohamed, Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles, Bioorg. Med. Chem. 14 (2006) 3672-3680; DOI: 10.1016/j.bmc.2006.01.033.
- 14. H. Rajak, C. K. Behera, R. S. Pawar, P. K. Singour and M. D. Kharya, A novel series of 2,5-disubstituted 1,3,4-thiadiazoles as potential anticonvulsant agent, Chin. Chem. Lett. 21 (2010) 1149-1152; DOI: 10.1016/j.cclet.2010.04.012.
- 15. I. R. Sadarangani, S. Bhatia, D. Amarante, I. Lengyel and R. A. Stephani, Synthesis, resolution and anticonvulsant activity of chiral N-1’-ethyl,N-3’-(1-phenylethyl)-(R,S)-2’H,3H,5’H-spiro-(2- benzofuran-1,4’-imidazolidine)-2’,3,5’-trione diastereomers, Bioorg. Med. Chem. Lett. 22 (2012) 2507-2509; DOI: 10.1016/j.bmcl.2012.02.005.
- 16. S. Rádl, P. Hezký, J. Urbánková, P. Váchal and I. Krejči, Synthesis and analgesic activity of some 1-benzofurans, 1-benzothiophenes and indoles, Collect. Czech. Chem. Commun. 65 (2000) 280-296.
- 17. C. Aswathanarayanappa, E. Bheemappa, Y. D. Bodke, V. K. Bhovi, R. Ningedowda, M. C. Shivakumar, S. K. Peethambar and S. Telkar, 5-Phenyl-1-benzofuran-2-yl derivatives, synthesis, antimicrobial, and antioxidant activity, Med. Chem. Res. 22 (2013) 78-87; DOI: 10.1007/s00044-12-0017-y.
- 18. T. Kosmalski, J. Kutkowska, A. K. Gzella and A. Nowakiewicz, New heterocyclic oxime ethers of 1-(benzofuran-2-yl)ethan-1-one and their antimicrobial activity, Acta Pol. Pharm. 72 (2015) 289-295.
- 19. J. Cho, C. Park, Y. Lee, S. Kim, S. Bose, M. Choi, A. S. Kumar, J. K. Jung and H. Lee, Neuroprotective and antioxidant effects of novel benzofuran-2-carboxamide derivatives, Biomol. Ther. (Seoul). 23 (2015) 275-282; DOI: 10.4062/biomolther.2015.030.
- 20. X. D. Yang, W. C. Wan, X. Y. Deng, Y. Li, L. J. Yang, L. Li and H. B. Zhang, Design, synthesis and cytotoxic activities of novel hybrid compounds between 2-phenylbenzofuran and imidazole, Bioorg. Med. Chem. Lett. 22 (2012) 2726-2729; DOI: 10.1016/j.bmcl.2012.02.094.
- 21. M. Choi, H. Jo, H. J. Park, A. S. Kumar, J. Lee, J. Yun, Y. Kim, S. B. Han, J. K. Jung, J. Cho, K. Lee, J. H. Kwak and H. Lee, Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB, Bioorg. Med. Chem. Lett. 25 (2015) 2545-2549; DOI: 10.1016/j.bmcl.2015.04.050.
- 22. H. Kwiecień, A. Goszczyńska and P. Rokosz, Benzofuran small molecules as potential inhibitors of human protein kinases, A Review, Curr. Pharm. Des. 22 (2015); DOI: 10.2174/1381612822-666151209152457.
- 23. B. Waltenberger, K. Wiechmann, J. Bauer, P. Markt, S. M. Noha, G. Wolber, J. M. Rollinger, O. Werz, D. Schuster and H. Stuppner, Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1), J. Med. Chem. 54 (2011) 3163-3174; DOI: 10.1021/jm101309g.
- 24. Z. Wang, S. Zhang, H. Jin, W. Wang, J. Huo, L. Zhou, Y. Wang, F. Feng and L. Zhang, Angiotensin- I-converting enzyme inhibitory peptides, Chemical feature based pharmacophore generation, Eur. J. Med. Chem. 46 (2011) 3428-3433; DOI: 10.1016/j.ejmech.2011.05.007.
- 25. S. K. Bansal, B. N. Sinha and R. L. Khosa, Docking-based virtual screening of Schiff’s bases of GABA: a prospective to novel GABA-AT inhibitors, Med. Chem. Res. 21 (2012) 3063-3072; DOI: 10.1007/s00044-011-9843-6.
- 26. R. Sinha, S. U. V. Singh, R. L. Khosa, J. P. Stables and J. Jain, Nicotinic acid hydrazones: a novel anticonvulsant pharmacophore, Med. Chem. Res. 20 (2011) 1499-1504; DOI: 10.1007/s00044-010-9396-0.
- 27. W. Loscher, C. P. Fassbender and B. Nolting, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models, Epilepsy Res. 8 (1991) 79-94.
- 28. H. G. Vogel. Drug Discovery and Evaluation. Pharmacological Assays, 2nd ed., Springer, Berlin 2002. 398-399, 422-427.
- 29. P. Yogeeswari, D. Sriram, R. Thirumurugan, J. V. Raghavendran, K. Sudhan, R. K. Pavana and J. Stables, Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants: Hybrid pharmacophore-based design, J. Med. Chem. 48 (2005) 6202-6211; DOI: 10.1021/jm050283b.
- 30. A. K. Shakya, G. K. Patnaik and P. Mishra, Synthesis and biological activity of 2-substituted ethanamido-5-alkyl-1,3,4-thiadiazoles: Part-III, Acta Pharm. Turc. 42 (2000) 56-63.
- 31. R. B. Brooks, R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan and M. Karplus, CHARMM-a program for macromolecular energy, minimization, and dynamics calculations, J. Comp. Chem. 4 (1983) 187-217; DOI: 10.1002/jcc.540040211.
- 32. R. D. K. Gehlhaar, D. Bouzida and P. A. Rejto, Fully Automated and Rapid Flexible Docking of Inhibitors Covalently Bound to Serine Proteases, in: Evolutionary Programming VII, Proceedings of the 7th International Conference EP98, San Diego, March 25-27, 1998, Springer, London 1998, pp. 449-461; DOI: 10.1007/BFb0040797.
- 33. J. M. Yang and C. C. Chen, Gemdock, A generic evolutionary method for molecular docking, Proteins 55 (2004) 288-304; DOI: 10.1002/prot.20035.
- 34. V. M. Balaramnavar, R. Srivastava, N. Rahuja, S. Gupta, A. K. Rawat, S. Varshney, H. Chandasana, Y. S. Chhonker, P. K. Doharey, S. Kumar, S. Gautam, S. P. Srivastava, R. S. Bhatta, J. K. Saxena, A. N. Gaikwad, A. K. Srivastava and A. K. Saxena, Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking, Eur. J. Med. Chem. 87 (2014) 578-594; DOI: 10.1016/j. ejmech.2014.09.097.